Literature DB >> 35838808

Retinal and choroidal vasoreactivity in central serous chorioretinopathy.

Susana Penas1,2, Teresa Araújo3,4, Ana Maria Mendonça3,4, Simão Faria3,4, Jorge Silva3,4, Aurélio Campilho3,4, Maria Lurdes Martins5, Vânia Sousa5, Amândio Rocha-Sousa5,6, Ângela Carneiro5,6, Fernando Falcão-Reis5,6.   

Abstract

PURPOSE: This study aims to investigate retinal and choroidal vascular reactivity to carbogen in central serous chorioretinopathy (CSC) patients.
METHODS: An experimental pilot study including 68 eyes from 20 CSC patients and 14 age and sex-matched controls was performed. The participants inhaled carbogen (5% CO2 + 95% O2) for 2 min through a high-concentration disposable mask. A 30° disc-centered fundus imaging using infra-red (IR) and macular spectral domain optical coherence tomography (SD-OCT) using the enhanced depth imaging (EDI) technique was performed, both at baseline and after a 2-min gas exposure. A parametric model fitting-based approach for automatic retinal blood vessel caliber estimation was used to assess the mean variation in both arterial and venous vasculature. Choroidal thickness was measured in two different ways: the subfoveal choroidal thickness (SFCT) was calculated using a manual caliper and the mean central choroidal thickness (MCCT) was assessed using an automatic software.
RESULTS: No significant differences were detected in baseline hemodynamic parameters between both groups. A significant positive correlation was found between the participants' age and arterial diameter variation (p < 0.001, r = 0.447), meaning that younger participants presented a more vasoconstrictive response (negative variation) than older ones. No significant differences were detected in the vasoreactive response between CSC and controls for both arterial and venous vessels (p = 0.63 and p = 0.85, respectively). Although the vascular reactivity was not related to the activity of CSC, it was related to the time of disease, for both the arterial (p = 0.02, r = 0.381) and venous (p = 0.001, r = 0.530) beds. SFCT and MCCT were highly correlated (r = 0.830, p < 0.001). Both SFCT and MCCT significantly increased in CSC patients (p < 0.001 and p < 0.001) but not in controls (p = 0.059 and 0.247). A significant negative correlation between CSC patients' age and MCCT variation (r =  - 0.340, p = 0.049) was detected. In CSC patients, the choroidal thickness variation was not related to the activity state, time of disease, or previous photodynamic treatment.
CONCLUSION: Vasoreactivity to carbogen was similar in the retinal vessels but significantly higher in the choroidal vessels of CSC patients when compared to controls, strengthening the hypothesis of a choroidal regulation dysfunction in this pathology.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  CSC; Carbogen; Central serous chorioretinopathy; Choroidal thickness; Vascular reactivity; Vasoreactivity

Year:  2022        PMID: 35838808     DOI: 10.1007/s00417-022-05757-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


  34 in total

Review 1.  Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease.

Authors:  Joanna Kur; Eric A Newman; Tailoi Chan-Ling
Journal:  Prog Retin Eye Res       Date:  2012-05-03       Impact factor: 21.198

Review 2.  Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis.

Authors:  Alejandra Daruich; Alexandre Matet; Ali Dirani; Elodie Bousquet; Min Zhao; Nicolette Farman; Frédéric Jaisser; Francine Behar-Cohen
Journal:  Prog Retin Eye Res       Date:  2015-05-27       Impact factor: 21.198

3.  Central serous chorioretinopathy and risk of ischaemic stroke: a population-based cohort study.

Authors:  Der-Chong Tsai; Chin-Chou Huang; Shih-Jen Chen; Pesus Chou; Chia-Min Chung; Wan-Leong Chan; Po-Hsun Huang; Tseng-Ji Chen; Shing-Jong Lin; Jaw-Wen Chen; Hsin-Bang Leu
Journal:  Br J Ophthalmol       Date:  2012-09-13       Impact factor: 4.638

Review 4.  Neural control of choroidal blood flow.

Authors:  Anton Reiner; Malinda E C Fitzgerald; Nobel Del Mar; Chunyan Li
Journal:  Prog Retin Eye Res       Date:  2017-12-08       Impact factor: 21.198

5.  Peripheral Vascular Endothelial Dysfunction in Central Serous Chorioretinopathy.

Authors:  Nan-Kai Wang; Yun Fu; Jung-Pan Wang; Eugene Yu-Chan Kang; An-Lun Wu; Yun-Ju Tseng; Lung-Kun Yeh; Kuan-Jen Chen; Wei-Chi Wu; Wan-Jing Ho; Chi-Chun Lai
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-09-01       Impact factor: 4.799

6.  Systemic findings associated with central serous chorioretinopathy.

Authors:  M K Tittl; R F Spaide; D Wong; E Pilotto; L A Yannuzzi; Y L Fisher; B Freund; D R Guyer; J S Slakter; J A Sorenson
Journal:  Am J Ophthalmol       Date:  1999-07       Impact factor: 5.258

7.  Digital indocyanine green videoangiography of central serous chorioretinopathy.

Authors:  D R Guyer; L A Yannuzzi; J S Slakter; J A Sorenson; A Ho; D Orlock
Journal:  Arch Ophthalmol       Date:  1994-08

8.  Choroidal capillary and venous congestion in central serous chorioretinopathy.

Authors:  C Prünte; J Flammer
Journal:  Am J Ophthalmol       Date:  1996-01       Impact factor: 5.258

9.  Long-term follow-up of central serous retinopathy in 150 patients.

Authors:  J Castro-Correia; M F Coutinho; V Rosas; J Maia
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

10.  Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study.

Authors:  San-Ni Chen; Yi-Chiao Chen; Iebin Lian
Journal:  Br J Ophthalmol       Date:  2013-10-29       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.